Article
Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histology.
American journal of kidney diseases : the official journal of the National Kidney Foundation - 1 Jul 2003
Kamar Nassim, Sandres-Saune Karine, Selves Janick, Ribes David, Cointault Olivier, Durand Dominique, Izopet Jacques, Rostaing Lionel
Abstract excerpt
BACKGROUND: Long-term renal transplant (RT) recipient mortality and graft loss increase significantly in hepatitis C virus positive (HCV-[+]ve) patients. Treatment with alpha-interferon in this population is associated with a high rate of acute rejection. The aims of this study were the evaluation of the efficacy and the safety of ribavirin monotherapy in 16 HCV-(+) RT patients (group A) matched to 32 HCV-(+) RT...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
